Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcadia Biosciences (RKDA) Inventory Average (2016 - 2025)

Arcadia Biosciences' Inventory Average history spans 11 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 53.48% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, up 53.48%, while the annual FY2025 figure was $1.1 million, 21.54% up from the prior year.
  • Inventory Average reached $1.3 million in Q4 2025 per RKDA's latest filing, down from $1.5 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $4.9 million in Q4 2021 to a low of $869500.0 in Q4 2024.
  • Average Inventory Average over 5 years is $2.4 million, with a median of $2.3 million recorded in 2021.
  • Peak YoY movement for Inventory Average: skyrocketed 85.35% in 2022, then plummeted 68.85% in 2024.
  • A 5-year view of Inventory Average shows it stood at $4.9 million in 2021, then plummeted by 42.68% to $2.8 million in 2022, then crashed by 38.3% to $1.7 million in 2023, then tumbled by 50.23% to $869500.0 in 2024, then soared by 53.48% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Inventory Average are $1.3 million (Q4 2025), $1.5 million (Q3 2025), and $1.4 million (Q2 2025).